Karyopharm Therapeutics
KPTI
KPTI
114 hedge funds and large institutions have $58.6M invested in Karyopharm Therapeutics in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
24
Reduced
33
Closed
26
Calls
$1.19M
Puts
$89K
Net Calls
+$1.1M
Net Calls Change
+$1.09M
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.24M |
| 2 |
Jane Street
New York
|
+$1.2M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.04M |
| 4 |
Millennium Management
New York
|
+$787K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$711K |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$5.45M |
| 2 |
BlackRock
New York
|
-$4.58M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.59M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.05M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$743K |
